Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Nicoletta Loggia currently holds 380 shares of Candel Therapeutics, Inc. (CADL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nicoletta Loggia has been a net neutral trader of CADL stock. They have purchased $0 and sold $0 worth of shares.
Nicoletta Loggia's most recent insider trade was on Sep 30, 2026, when they sold 380 shares at $8.68 per share.
Nicoletta Loggia serves as Executive at Candel Therapeutics, Inc. (CADL). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Nicoletta Loggia holds the position of Executive at Candel Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Nicoletta Loggia has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Nicoletta Loggia was on Sep 30, 2026, when they purchased $3.3K worth of CADL shares. This transaction involved 380 shares at $8.68 per share.
Nicoletta Loggia currently owns 380 shares of Candel Therapeutics, Inc. (CADL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Nicoletta Loggia's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Nicoletta Loggia has 2 Form 4 filings on record as an insider at Candel Therapeutics, Inc..
Set alerts for Nicoletta Loggia and 40,000+ other insiders.